Our top pick for
Ciner Resources LP is a chemicals business based in the US. Ciner Resources shares (CINR) are listed on the NYSE and all prices are listed in US Dollars.
|Latest market close||$16.02|
|52-week range||$10.43 - $16.97|
|50-day moving average||$14.42|
|200-day moving average||$13.63|
|Wall St. target price||$24.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.67|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-18)||-2.79%|
|1 month (2021-09-24)||23.80%|
|3 months (2021-07-26)||12.03%|
|6 months (2021-04-26)||24.96%|
|1 year (2020-10-23)||34.51%|
|2 years (2019-10-25)||-9.54%|
|3 years (2018-10-25)||25.7781|
|5 years (2016-10-25)||31.75|
Valuing Ciner Resources stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ciner Resources's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ciner Resources's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Ciner Resources shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ciner Resources's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $68.6 million.
The EBITDA is a measure of a Ciner Resources's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$450.1 million|
|Operating margin TTM||8.02%|
|Gross profit TTM||$82.9 million|
|Return on assets TTM||4.47%|
|Return on equity TTM||10.12%|
|Market capitalisation||$316.9 million|
TTM: trailing 12 months
There are currently 7,513 Ciner Resources shares held short by investors – that's known as Ciner Resources's "short interest". This figure is 503% up from 1,246 last month.
There are a few different ways that this level of interest in shorting Ciner Resources shares can be evaluated.
Ciner Resources's "short interest ratio" (SIR) is the quantity of Ciner Resources shares currently shorted divided by the average quantity of Ciner Resources shares traded daily (recently around 23478.125). Ciner Resources's SIR currently stands at 0.32. In other words for every 100,000 Ciner Resources shares traded daily on the market, roughly 320 shares are currently held short.
However Ciner Resources's short interest can also be evaluated against the total number of Ciner Resources shares, or, against the total number of tradable Ciner Resources shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ciner Resources's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Ciner Resources shares in existence, roughly 0 shares are currently held short) or 0.0015% of the tradable shares (for every 100,000 tradable Ciner Resources shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ciner Resources.
Find out more about how you can short Ciner Resources stock.
We're not expecting Ciner Resources to pay a dividend over the next 12 months.
Over the last 12 months, Ciner Resources's shares have ranged in value from as little as $10.43 up to $16.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ciner Resources's is 0.809. This would suggest that Ciner Resources's shares are less volatile than average (for this exchange).
Ciner Resources LP, together with its subsidiaries, engages in the trona ore mining and soda ash production businesses in the United States and internationally. It processes trona ore into soda ash, which is a raw material in flat glass, container glass, detergents, chemicals, paper, and other consumer and industrial products. The company holds approximately 23,500 acres of leased and licensed subsurface mining areas in the Green River Basin of Wyoming. As of December 31, 2020, it had proven and probable reserves of approximately 208. 2 million short tons of trona. Ciner Resource Partners LLC serves as the general partner of the company. The company was formerly known as OCI Resources LP and changed its name to Ciner Resources LP in November 2015.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.